TESTOSTERONE Supplement Litigation

Heart Attack, Stroke or Death Associated With Testosterone Replacement Therapies

On January 31, 2014, the Food & Drug Administration announced that it has launched an investigation into the risks of testosterone replacement therapy through the use of products such as AndroGel®, AndroDerm®, Axiron®, Testim® and other testosterone treatments, due to alarming new research that suggests that millions of men may be at risk for a heart attack, stroke or premature death by taking testosterone therapy they don't actually need. See http://www.fda.gov/safety/medwatch/safety information/safetyalertsforhumanmedicalproducts/ucm384225.htm. Lawsuits related to the use of testosterone replacement therapy for so-called "low t" which seek compensation for such injuries have already been filed in Federal District Court.

A study published just two days before the FDA announcement in the respected medical journal PLoS ONE, found that prescription testosterone can double the rate of heart attacks in men 65 and older and triple the risks in younger men who have some history of heart disease. Another study published by the Journal of the American Medical Association found that men age 60 and older using testosterone drugs had a 30 percent greater risk for stroke, heart attack, and death compared to those who didn't use testosterone replacement drugs.

About Testosterone Replacement Therapy

According to the FDA, prescription testosterone is only indicated for men with demonstrated low testosterone levels and an associated medical condition known as "hypogonadism." In recent years, the use of testosterone replacement treatments has increased radically, largely due to increased advertising by the manufacturers of testosterone products, like that on websites like www.isitlowt.com and www.low-testosterone-option.com. The number of testosterone prescriptions given to American men has tripled since 2001, and sales were estimated at $2 billion in 2012. In 2012, three million (3,000,000) prescriptions were written for the market leader AndroGel® alone.

In the past several years, manufacturers of testosterone replacement therapies have aggressively marketed their product for treatment of the common and natural effects of aging in men - symptoms such as normal decline in sexual drive, energy and athleticism, by describing these effects as a new medical condition called "Low T." According to industry, such symptoms call for treatment with testosterone replacement therapy and a prescription for one of their testosterone supplement products. While testosterone has been in limited clinical use since 1937 and approved by the FDA since 1953, testosterone can now be administered by patients at home, and the drug comes in at least five forms, including patches, gels and injections.

Testosterone Replacement Therapy Lawsuits

The experienced pharmaceutical liability attorneys at MacDonald Rothweiler Eisenberg LLP are currently investigating cases related to injuries suffered while receiving testosterone replacement therapy and testosterone supplements for "Low T." We have significant experience in handling prescription drug liability cases for clients throughout the country. We are committed to protecting our clients' rights and making drugs safer for the general public.

If you believe you or a loved one has a potential claim regarding prescription testosterone, the law firm of MacDonald Rothweiler Eisenberg LLP can evaluate your claim. Contact us at info@mrelegal.com or at 866-569-3400 today.